EP0843660A1 - Heterocyclische verbindungen, deren herstellung und verwendung. - Google Patents

Heterocyclische verbindungen, deren herstellung und verwendung.

Info

Publication number
EP0843660A1
EP0843660A1 EP96924801A EP96924801A EP0843660A1 EP 0843660 A1 EP0843660 A1 EP 0843660A1 EP 96924801 A EP96924801 A EP 96924801A EP 96924801 A EP96924801 A EP 96924801A EP 0843660 A1 EP0843660 A1 EP 0843660A1
Authority
EP
European Patent Office
Prior art keywords
indolyl
alkyl
chloro
compound
defined above
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP96924801A
Other languages
English (en)
French (fr)
Inventor
Jane Marie Lundbeck
Anders Kanstrup
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of EP0843660A1 publication Critical patent/EP0843660A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP96924801A 1995-07-31 1996-07-31 Heterocyclische verbindungen, deren herstellung und verwendung. Withdrawn EP0843660A1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK87095 1995-07-31
DK87095 1995-07-31
PCT/DK1996/000332 WO1997005109A1 (en) 1995-07-31 1996-07-31 Heterocyclic compounds, their preparation and use

Publications (1)

Publication Number Publication Date
EP0843660A1 true EP0843660A1 (de) 1998-05-27

Family

ID=8098461

Family Applications (1)

Application Number Title Priority Date Filing Date
EP96924801A Withdrawn EP0843660A1 (de) 1995-07-31 1996-07-31 Heterocyclische verbindungen, deren herstellung und verwendung.

Country Status (4)

Country Link
EP (1) EP0843660A1 (de)
JP (1) JPH11509847A (de)
AU (1) AU6514296A (de)
WO (1) WO1997005109A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW544448B (en) 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
DE19801647A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte beta,gamma-annellierte Lactone
DE19801646A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte alpha,beta-annellierte Butyrolactone
DE19801636A1 (de) 1998-01-17 1999-07-22 Bayer Ag Substituierte bicyclische Lactone
AU2241400A (en) 1999-04-06 2000-10-12 Yamanouchi Pharmaceutical Co., Ltd. Novel thiazolobenzoimidazole derivative
CZ20021663A3 (cs) 1999-10-15 2002-09-11 F. Hoffmann-La Roche Ag Nové deriváty benzodiazepinu
BR0014859A (pt) * 1999-10-15 2002-07-16 Hoffmann La Roche Derivados de benzodiazepina
MX2007003922A (es) * 2004-10-05 2007-06-07 Merz Pharma Gmbh & Co Kgaa Nuevas propenonas ciclicas y aciclicas para tratar trastornos del sistema nervioso central.
ES2600460T3 (es) 2005-05-10 2017-02-09 Intermune, Inc. Derivados de piridona-2-ona como moduladores del sistema de proteína cinasa activada por estrés
CA2670116C (en) 2006-11-22 2015-03-10 Seaside Therapeutics, Llc Methods of treating mental retardation, down's syndrome, fragile x syndrome and autism
CN101657432B (zh) 2007-04-19 2013-04-10 弗·哈夫曼-拉罗切有限公司 二氢-苯并[b][1,4]二氮杂*-2-酮磺酰胺衍生物
CA2726588C (en) 2008-06-03 2019-04-16 Karl Kossen Compounds and methods for treating inflammatory and fibrotic disorders
WO2011109398A2 (en) 2010-03-02 2011-09-09 President And Fellows Of Harvard College Methods and compositions for treatment of angelman syndrome and autism spectrum disorders
US20110294879A1 (en) 2010-05-28 2011-12-01 Xenoport, Inc. Method of treatment of fragile x syndrome, down's syndrome, autism and related disorders
US20120016021A1 (en) 2010-07-15 2012-01-19 Xenoport, Inc. Methods of treating fragile x syndrome, down's syndrome, autism and related disorders
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
WO2015153683A1 (en) 2014-04-02 2015-10-08 Intermune, Inc. Anti-fibrotic pyridinones
WO2017196936A1 (en) * 2016-05-12 2017-11-16 Regents Of The University Of Minnesota Indole and indazole cyanocinnamate compounds and therapeutic uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931230A (en) * 1974-04-12 1976-01-06 Warner-Lambert Company 3-Substituted isotryptamine derivatives and process for their production
ES2088011T3 (es) * 1990-07-16 1996-08-01 Merrell Pharma Inc Antagonistas de aminoacidos excitadores.
US5284862A (en) * 1991-03-18 1994-02-08 Warner-Lambert Company Derivatives of 2-carboxyindoles having pharmaceutical activity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO9705109A1 *

Also Published As

Publication number Publication date
JPH11509847A (ja) 1999-08-31
AU6514296A (en) 1997-02-26
WO1997005109A1 (en) 1997-02-13

Similar Documents

Publication Publication Date Title
US5945417A (en) Heterocyclic compounds, their preparation and use
EP0750621B1 (de) Heterocyclische verbindungen, ihre herstellung und verwendung
WO1997005109A1 (en) Heterocyclic compounds, their preparation and use
WO1996015099A1 (en) Heterocyclic compounds, their preparation and use
US5696148A (en) Indole compounds and their use in treating diseases of the central nervous system
US5783575A (en) Antagonists, their preparation and use
US20120015966A1 (en) Ppar active compounds
CN101304992A (zh) 用作ppar调节剂的1,3-二取代吲哚衍生物
WO2007030574A2 (en) 1 , 4 and 1 , 5-disubstituted indole derivatives for use as ppar active compounds
DE19719621A1 (de) Sulfonylaminocarbonsäuren
KR102232744B1 (ko) Ｐ２ｘ７ 수용체 길항제로서의 인돌 카르복사미드 유도체
EP0866059A1 (de) Neue heterozyklische derivate und ihre medizinische anwendung
KR20090101307A (ko) 스핑고신-1-포스페이트(ｓ1ｐ) 수용체 길항제 생물학적 활성을 갖는 6-치환된 인돌-3-카르복실산 아미드 화합물
JP6653410B2 (ja) ＮａＰｉ−ＩＩｂ阻害剤として有用な縮合チオフェン誘導体
AU2008320718B2 (en) Indol-2-one derivatives disubstituted in the 3-position, preparation thereof and therapeutic use thereof
HUE031453T2 (en) Substituted benzamides having activity against EP4 receptors
FR2824827A1 (fr) Nouveaux derives de 5-phenyl-1h-indole antagoniste des recepteurs de l'interleukine-8
WO2015139619A1 (zh) 作为RORγ调节剂的化合物
JP2012522796A (ja) プロスタグランジンｅレセプター拮抗薬
JP2001506243A (ja) 複素環式カルボン酸誘導体、その製造およびエンドセリン受容体拮抗物質としての使用
EP3983387B1 (de) Sulfonylharnstoffderivate und ihre verwendungen
CZ20032260A3 (cs) Nové deriváty 5-kyano-1H-indolových antagonistů receptorů interleukinu-8
KR101183553B1 (ko) 퀴녹살린 유도체 또는 이의 염을 유효성분으로 포함하는 암 예방 또는 치료용 약학 조성물
JPS6040420B2 (ja) ３−アミノ−２−（５−フルオル−及び５−メトキシ−１ｈ−インド−ル−３−イル）プロパン酸誘導体類、その製法及び利用
MXPA96004023A (es) Compuestos heterociclicos, su preparacion y su

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19980302

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU NL PT SE

17Q First examination report despatched

Effective date: 20000201

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20000614